1- [2' , 3' -dideoxy-3' C- (hydroxymethyl) - beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors

Details for Australian Patent Application No. 2006268743 (hide)

Owner Medivir AB

Inventors Zhou, Xiao-Xiong; Sahlberg, Christer

Agent Davies Collison Cave

Pub. Number AU-B-2006268743

PCT Pub. Number WO2007/006707

Priority 0513835.9 07.07.05 GB

Filing date 5 July 2006

Wipo publication date 18 January 2007

Acceptance publication date 29 July 2010

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/006707 Priority application(s): WO2007/006707

29 July 2010 Application Accepted

  Published as AU-B-2006268743

16 December 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Aug 2010 2007

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268747-Marked inorganic additives

2006268736-Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors